Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Sundaram Multi Pap Ltd.
Source DateBoard Meeting DateDetails
04-Nov-2025 13-Nov-2025 Quarterly Results
07-Oct-2025 16-Oct-2025 Inter alia; 1. To consider and if found fit and appropriate, approve the valuation reports received from the appointed valuers in relation to the proposed acquisition of around 52.38% equity stake in Sundaram Land and Assets Private Limited on a share swap basis. 2. If found fit, approve the acquisition of M/s. Sundaram Land and Assets Private Limited and issuance of Equity Shares of the Company to Non promoter group/ Category through Preferential private placement (for consideration other than cash) to acquire around 52.38% shares of M/s. Sundaram Land and Assets Private Limited subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 3. If the above two points are considered and approved by the Board, to Fix the date, Venue to convene EGM of the company and also to approve the draft notice convening of EGM for taking the shareholders approval for the above said acquisition. 4. Any other matter with the permission of chair
14-Aug-2025 25-Aug-2025 Inter alia, to: 1. Consider and approve the valuation reports received from the appointed valuers in relation to the proposed acquisition of 53% equity stake in Sundaram Land and Assets Private Limited on a share swap basis. 2. If found fit, approve the proposal for the said acquisition and the issuance of equity shares of the Company as consideration, subject to necessary approvals. 3. Approve the draft Notice convening the 31st Annual General Meeting of the Company, including resolutions for: a. Adoption of the Audited Financial Statements for the year ended on March 31, 2025 and related reports. b. If found fit in Board Meeting on August 25, 2025, approval of the proposed acquisition. 4. Approve the Directors Report for the financial year ended on March 31, 2025 and other matters incidental thereto.
06-Aug-2025 12-Aug-2025 Quarterly Results
13-May-2025 22-May-2025 Audited Results
26-Mar-2025 29-Mar-2025 Inter-alia, to consider and approve, subject to the receipt of in-principle approvals from BSE Limited and NSE, the allotment of sweat equity shares to eligible employees and directors of the Company pursuant to the ordinary resolution passed at the Extra-Ordinary General Meeting held on February 24, 2025, in accordance with: ? Section 54 of the Companies Act, 2013 ? Rule 8 of the Companies (Share Capital and Debentures) Rules, 2014 ? Chapter IV of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
07-Feb-2025 14-Feb-2025 Quarterly Results
20-Jan-2025 27-Jan-2025 Inter alia, to consider and approve following business transactions: 1. Proposal for the issuance of sweat equity shares to directors: ? To recognize and reward the exceptional contributions of the directors, Mr. Amrut P Shah and Mr. Shantilal P Shah, who have rendered outstanding services to the Company over the past 35 years since its inception by way of issuing equity shares to them subject to obtaining the approval of the shareholders of the Company. ? To finalize the number, price, terms, and conditions for the issuance of sweat equity shares in accordance with the valuation reports obtained from the approved valuers, and sweat equity share scheme, and to discuss compliances with reference to: o Section 54 of the Companies Act, 2013, and relevant rules thereunder. o Regulation 14 of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. 2. Board Approval for convening an Extra Ordinary General Meeting (EGM): ? To seek Board approval for holding an EGM for the issuance of sweat equity shares by way of a special resolution, and to finalize the draft EGM notice and other related aspects. 3. Any other business with the permission of the Chair.
05-Nov-2024 14-Nov-2024 Quarterly Results
02-Sep-2024 09-Sep-2024 Inter alia, to consider and approve: the appointment of Company Secretary and Compliance Officer
05-Aug-2024 12-Aug-2024 Quarterly Results
21-Jun-2024 02-Jul-2024 Inter-alia: 1- To consider and approve the date, time and venue of Extraordinary General Meeting. 2- To consider and approve the draft Notice of Extraordinary General Meeting. 3- To consider and approve the appointment of scrutinizer for the Extraordinary General Meeting. 4- To consider any other business with the permission of the Chair.
16-May-2024 28-May-2024 Audited Results
13-Mar-2024 27-Mar-2024 Inter alia, to consider and approve the appointment of Statutory Auditor to fill the casual vacancy caused due to death
01-Feb-2024 13-Feb-2024 Quarterly Results
27-Oct-2023 06-Nov-2023 Quarterly Results
12-Sep-2023 18-Sep-2023 General Purpose
01-Aug-2023 11-Aug-2023 Quarterly Results
19-May-2023 29-May-2023 Audited Results
30-Jan-2023 13-Feb-2023 Quarterly Results
Page 1 of 7
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.